A Dutch guideline for the treatment of scoliosis in neuromuscular disorders by Mullender, MG et al.
BioMed  Central
Page 1 of 14
(page number not for citation purposes)
Scoliosis
Open Access Review
A Dutch guideline for the treatment of scoliosis in neuromuscular 
disorders
MG Mullender*1, NA Blom2, M De Kleuver3, JM Fock4, WMGC Hitters5, 
AMC Horemans6, CJ Kalkman7, JEH Pruijs8, RR Timmer9, PJ Titarsolej10, 
NC Van Haasteren11, MJ Van Tol-de Jager12, AJ Van Vught13 and BJ Van 
Royen1
Address: 1Dept. Orthopaedic Surgery, Vrije Universiteit Medical Center (VUmc), Research Institute MOVE, Amsterdam, The Netherlands, 
2Department of Pediatric Cardiology, Leiden University Medical Center, The Netherlands, 3Dept. Orthopaedics, Sint Maartenskliniek, Nijmegen, 
The Netherlands, 4Dept. Neurology, University Hospital Groningen, The Netherlands, 5Revalidatiecentrum Blixembosch, Eindhoven, The 
Netherlands, 6Vereniging Spierziekten Nederland, Baarn, The Netherlands, 7Dept. Perioperative & Emergency Care, University Medical Centre 
Utrecht, The Netherlands, 8Department of Paediatric Orthopaedics, University Hospital for Children and Youth Het Wilhelmina 
Kinderziekenhuis, Utrecht, The Netherlands, 9Dept Anesthesiologie, University Hospital Maastricht, The Netherlands, 10Groot Klimmendaal, 
Arnhem, The Netherlands, 11Revalidatiecentrum Leijpark, Tilburg, The Netherlands, 12Revalidatiecentrum de Hoogstraat en Wilhelmina 
Kinderziekenhuis UMC Utrecht, The Netherlands and 13Department of Paediatrics, University Hospital for Children and Youth Het Wilhelmina 
Kinderziekenhuis, Utrecht, The Netherlands
Email: MG Mullender* - m.mullender@vumc.nl; NA Blom - n.a.blom@lumc.nl; M De Kleuver - m.dekleuver@maartenskliniek.nl; 
JM Fock - j.m.fock@neuro.umcg.nl; WMGC Hitters - mhitters@blixembosch.nl; AMC Horemans - anja.horemans@vsn.nl; 
CJ Kalkman - c.j.kalkman@umcutrecht.nl; JEH Pruijs - h.pruijs@umcutrecht.nl; RR Timmer - rti@sane.azm.nl; 
PJ Titarsolej - p.titarsolej@grootklimmendaal.nl; NC Van Haasteren - n.van.haasteren@rcleijpark.nl; MJ Van Tol-
de Jager - m.v.tol@dehoogstraat.nl; AJ Van Vught - a.vanvught@umcutrecht.nl; BJ Van Royen - bj.vanroyen@vumc.nl
* Corresponding author    
Abstract
Background: Children with neuromuscular disorders with a progressive muscle weakness such as Duchenne Muscular
Dystrophy and Spinal Muscular Atrophy frequently develop a progressive scoliosis. A severe scoliosis compromises respiratory
function and makes sitting more difficult. Spinal surgery is considered the primary treatment option for correcting severe
scoliosis in neuromuscular disorders. Surgery in this population requires a multidisciplinary approach, careful planning, dedicated
surgical procedures, and specialized after care.
Methods: The guideline is based on scientific evidence and expert opinions. A multidisciplinary working group representing
experts from all relevant specialties performed the research. A literature search was conducted to collect scientific evidence in
answer to specific questions posed by the working group. Literature was classified according to the level of evidence.
Results: For most aspects of the treatment scientific evidence is scarce and only low level cohort studies were found.
Nevertheless, a high degree of consensus was reached about the management of patients with scoliosis in neuromuscular
disorders. This was translated into a set of recommendations, which are now officially accepted as a general guideline in the
Netherlands.
Conclusion: In order to optimize the treatment for scoliosis in neuromuscular disorders a Dutch guideline has been composed.
This evidence-based, multidisciplinary guideline addresses conservative treatment, the preoperative, perioperative, and
postoperative care of scoliosis in neuromuscular disorders.
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Introduction
Neuromuscular disorders comprise a very diverse group of
disorders. The most common forms of neuromuscular
disorders are Duchenne Muscular Dystrophy (DMD) of
the myopathic disorders and Spinal Muscular Atrophy
(SMA) of the neurogenic disorders. Despite differences in
etiology both forms have a lot of characteristics in com-
mon. Both disorders have a genetic origin and have an
effect on several systems, requiring a multidisciplinary
evaluation and treatment. Typical for both of these disor-
ders is the progressive character of the muscle weakness
and as a result ventilatory restriction and a progressive
scoliosis. Usually joint contractures, as well as nutritional
disorders are present. In dystrophinopathy, cardiac dys-
function and mental retardation can occur as well.
Severe scoliosis causes discomfort and compromises res-
piratory function. Spinal surgery is considered the primary
treatment option for correcting severe scoliosis in neu-
romuscular disorders. It can improve the cardio-pulmo-
nary function, the sitting balance, appearance, and the
quality of life. However, in this population surgery is con-
sidered a major intervention with high risk. Careful pre-
operative evaluation should not be restricted to the spinal
deformity itself, but anesthetic management, pediatric
cardio-pulmonary care, postoperative intensive care and
rehabilitation should be emphasized. Several issues con-
cerning the surgical intervention are still controversial. For
instance, what is the best time point for surgery, and is sur-
gery always needed? Due to these uncertainties, the VSCA,
a cooperation of various institutions and patients' associ-
ations of patients on assisted ventilation, experienced
some difficulties and inconsistencies in the management
of scoliosis treatment in patients with DMD and SMA in
the Netherlands. It was proposed that the management of
scoliosis in neuromuscular disorders could benefit from
clear guidelines and more uniformity in definitions, and
terminology, amongst the various disciplines involved.
The effectiveness and safety of scoliosis surgery in DMD
patients was recently reviewed [1]. Due to the absence of
randomized controlled clinical trials the authors recom-
mended to refer to anecdotal evidence and expert opin-
ions in order to guide decision making in scoliosis
surgery. Hence, a multidisciplinary study group "guide-
lines scoliosis in neuromuscular disorders" started with
the development of multidisciplinary guidelines based on
the Dutch situation.
Objectives
The objective of the Dutch guideline for the treatment of
scoliosis in neuromuscular disorders is to present recom-
mendations based on the evidence available in systematic
reviews, randomized controlled trials, supplemented by
cohort studies, and expert opinions. These recommenda-
tions are directed at a wide range of professionals dealing
with the management of patients with scoliosis as a result
of neuromuscular disease. The guideline strives for a
multidisciplinary consensus about terminology, diagnos-
tics, indications for surgery, surgical treatment, follow-up
and patient education. Hence, the guideline supports a
multidisciplinary approach and encourages collaboration
between the different disciplines involved.
Target population
The guideline is directed at professionals concerned with
the management of scoliosis in patients with a neuromus-
cular disorder, and the professional associations that are
involved in the treatment or care for these patients. Indi-
rectly, these guidelines may inform relatives, and people
otherwise engaged in the care for patients with neuromus-
cular disorders, educational organizations, and the gen-
eral public.
Guidelines working group
The guideline was developed by a multidisciplinary group
of experts in the field of neuromuscular scoliosis manage-
ment. All relevant specialties involved in diagnostics and
treatment were represented. In addition, representatives
from societies of interest participated in the working
group in order to create a sound basis for the application
of the guideline.
The working method employed consisted of: 1) identifica-
tion of problems by the working group, 2) translation into
specific questions, 3) search of scientific evidence by sub-
groups in answer to the questions posed, 4) discussion of
the evidence in the complete working group and 5) resolv-
ing the recommendations for best practice by the working
group.
Evidence
The guideline is based on evidence from the available sci-
entific publications and expert opinions. The evidence
was categorized according to its strength (Table 1). Conse-
quently, the strength of the recommendations is graded
based on the level of evidence (Table 2).
Definitions
Neuromuscular disorder
The general definition of a neuromuscular disorder is a
disease pertaining to both the nerves and the muscles.
However, the term appeared to be interpreted differently
within the various disciplines. Hence, a more specific def-
inition was proposed. In this guideline, a neuromuscular
disorder is defined as a defective function of the periph-
eral nerve system, the neuromuscular junction, or mus-
cles, causing muscle weakness in the patient. Disorders of
the central nervous system, such as cerebral palsy or spina
bifida, are not included in this definition. Within this def-
inition, neuromuscular disorders are the result of defec-Scoliosis 2008, 3:14 http://www.scoliosisjournal.com/content/3/1/14
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tive anterior horn cell function in the spinal cord (e.g.
SMA), defects of the peripheral nerves (neuropathies), the
neuromuscular junction (myasthenia gravis), structural
defects of the muscle cells (myopathies), muscle cell deg-
radation (muscular dystrophies), or metabolic myopa-
thies (glycogenosis, mitochondrial myopathy). Most of
these disorders are rare. Therefore, the relatively frequent
occurring progressive disorders DMD and SMA, both
associated with a high incidence of scoliosis, were taken as
paradigm for the treatment of neuromuscular scoliosis.
Duchenne Muscular Dystrophy (DMD)
DMD is an X-linked (Xp21) recessive inherited disease.
Affected males inherited the genetic mutation from the
mother, or developed the condition by spontaneous
mutations in the gene. Usually, the affected boy has a
slightly delayed motor development during infancy. Here-
after, symptoms are a rapidly progressive muscle weak-
ness associated with muscle wasting associated with a
progressive difficulty to walk. Most boys are wheelchair-
bound at the age of 10. Major changes during puberty are
the progressive muscle weakness in hands, arms, and
torso, associated with the development of scoliosis. In this
phase, the respiratory function is gradually deteriorating,
with need of respiratory assistance, and a possible cardio-
myopathy may induce problems. Mild mental retardation
is present in approximately 40% of DMD patients.
DMD is diagnosed by repeated determination of
extremely elevated Creatine Kinase (CPK-MM) levels in
the bloodstream and mutations in the dystrophin gene on
the X-chromosome, or by the absence of the gene product
dystrophin in a muscle biopsy.
Spinal Muscular Atrophy (SMA)
SMA includes a number of genetic disorders, all present-
ing with a manifestation of weakness due to loss of the
motor neurons of the spinal cord and brainstem. The
most common form of SMA is caused by a mutation of the
Survival Motor Neuron (SMN) gene, located on chromo-
some 5q13. It is an autosomal recessive form which man-
ifests over a wide range of severity affecting infants
through adults. The spectrum has been classified into four
types based on the onset of the symptoms and the level of
weakness.
SMA type 1, also known as severe infantile SMA or Werd-
nig Hoffmann disease, is the most severe, and manifests in
the first year of life with the inability to ever maintain an
independent sitting position. Children with SMA type 1
deteriorate rapidly and have a life expectancy of less than
two years.
SMA type 2, or intermediate SMA, describes those children
who are wheelchair-bound very early in life. Usually, they
are never able to walk and a severe dystrophy associated
Table 1: Classification of evidence.
Papers concerning interventions (prevention or therapy)
A1 Systematic reviews discussing at least a few studies of A2-level, and in which the results of the distinctive studies discussed are consistent;
A2 Randomized controlled trials (RCTs) of good quality (randomized double blind controlled trials) involving a sufficient number of subjects, and 
employing suitable research methods;
B Generally consistent findings of weaker scientific studies (not randomized, comparative cohort studies, patient -control studies);
C non-comparative studies;
D expert opinions.
Papers concerning diagnosis
A1 Prospective studies of the effects of diagnostics on clinical outcome in a well defined patient group. The outcome parameters are well defined 
in advance.
Good quality studies of decision-making with respect to diagnostics and clinical outcomes;
A2 Studies of diagnostic tests compared to a reference test. Criteria and outcomes are well-defined in advance, and the test and the study 
population are adequately described. The study population must be sufficiently large. Independent observers have assessed the test results. 
The experimental and reference tests are evaluated independently. In cases where multiple diagnostic tests are used, the analysis should be 
adapted for interdependency of the results (e.g. by using logistic regression);
B Studies of diagnostic tests compared to a reference test. The test and population are described but the study is of less quality than described 
in level A;
C non-comparative studies;
D expert opinions.
Table 2: Grading of the recommendations according to the level of evidence.
Level 1 At least one systematic review (A1) or at least 2 independent studies with evidence level A1 or A2
Level 2 At least two independent studies with evidence level B
Level 3 One study with evidence level A2 or B or multiple studies of level C
Level 4 Expert opinionScoliosis 2008, 3:14 http://www.scoliosisjournal.com/content/3/1/14
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with considerable scoliosis develops already around the
age of four. Some of the children depend on respiratory
assistance during the night, and later around the clock,
with or without tracheostomy. The onset of weakness is
usually recognized some time between 6 and 18 months.
Within the first three years SMA types 1 and 2 cannot be
distinguished based on determination of the genetic
lesion. Consequently, this is a very uncertain period for
the parents.
SMA type 3, also called juvenile SMA or Kugelberg-
Welander disease has a more moderate course. Patients
with SMA type 3 preserve their ability to walk until the sec-
ond or third decade, and they develop less scoliosis and
respiratory problems.
In SMA type 4, or adult SMA weakness usually begins in
the third decade. The course of disease is much slower and
has little or no impact on life expectancy.
This guideline is directed at the group of patients with
SMA type 2.
SMA is diagnosed by the typical clinical symptoms and by
the SMN gene test.
Spinal deformation
Scoliosis is a complex deformation that involves abnor-
mal lateral and rotational curvature of the spine. Both in
DMD and SMA type 2 scoliotic deformations are frequent.
The deformation is mostly a progressive thoracolumbar
C-curve with development of pelvic obliquity. Either an
increased kyphosis or thoracic lordosis can be part of the
deformity. The consequences of the deformity are loss of
sitting balance, shortening of the trunk, and compression
of the hart and lungs. The mobility of the ribs is reduced
by rotation and deformation of the trunk, causing
obstruction of the breathing capacity.
Epidemiology – incidence and prevalence of 
scoliosis
Epidemiologic data regarding scoliosis in DMD are pro-
vided by a few studies [2-5]. However, most studies are
dated before the availability of DNA diagnostics. Possibly,
Becker Muscular Dystrophy (BMD) is included in some of
these study groups. This may be associated with a lower
incidence of scoliosis reported in the earlier studies.
Development of scoliosis in DMD patients is strongly
related to the loss of walking ability. Generally, ambula-
tory patients do not develop a scoliosis. However, as the
patient's walking ability deteriorates and patients become
wheelchair dependent, scoliosis starts to develop, mostly
in the thoracolumbar region. Neither severity nor rate of
progression can be predicted from the age at which spinal
collapse occurs or the age at which ambulatory ability is
lost [3,5]. The incidence of spinal deformity in DMD var-
ies between reports. No uniform method is used to
describe the development of scoliosis. Oda et al. [3]
define three types of spinal deformity, where type 3 is the
type with the least deformity; a Cobb angle < 30°. They
report that 15% (7/46) of patients who lost their walking
ability belong to this group. Brooke et al. [2] reported that
75% of 120 patients developed a curve between 30° and
120°. In an early study of 60 DMD patients the incidence
of scoliosis, defined as a curve between 5° and 120°, was
50% [4]. In a more recent study 76% of untreated patients
(24) and 17% of patients treated with corticosteroids (30)
developed a scoliosis with a curve > 20° [6].
All children with SMA type 2 develop scoliosis starting
from an early age of around 3 years [7,8]. At ten years of
age the average curve is more than 54° [8]. In 80% of the
cases the scoliosis is a low thoracic curve. The single curve
is most prevalent (83%), however 17% of the patients
develop a double curve [8].
Natural course of scoliosis
Data about the natural history of curve progression and
the relationship between scoliosis, morbidity, and mortal-
ity are lacking. Although relationships have been sug-
gested [2,3,9] such relationships have not been
substantiated by data.
1. Conservative phase
Factors affecting the progression of scoliosis in DMD
Evidence
Indications exist that not all patients with DMD develop a
scoliosis. The natural course of scoliosis in DMD patients
was studied by Oda et al. [3] and Yamashita et al. [10].
Oda et al. conclude that there is no indication for surgery
when the Cobb's angle is less than 30° in 15 year old
patients. This is the case in 15% of the described patient
group. Yamashita et al. argue that in order to determine
early which DMD patients need surgical intervention for
treatment of spinal deformity, criteria should be devel-
oped to predict the progression of the deformity in the
individual patient at an earlier age than 14 or 15 years. To
predict which patients at the age of 10 are likely to
develop a severe scoliosis they studied a group of 12
patients retrospectively and performed multiple discrimi-
nant analysis. The vital capacity (VC), and Cobb angle of
spinal scoliosis at the age of 10 years, the age at which
ambulation ceased, and the curve pattern of spinal scolio-
sis were found to be predictors for the progression of sco-
liosis. They propose a model based on these predictors to
guide the judgment whether surgical stabilization of the
spine should be considered.Scoliosis 2008, 3:14 http://www.scoliosisjournal.com/content/3/1/14
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Discussion/conclusion
In the absence of DNA verification it is unsure if all
patients in the studies of Oda et al. [3] and Yamashita et
al. [10] are DMD patients. Possibly, patients with BMD
were included as well. Hence, the percentage of DMD
patients that do not develop a scoliosis remains uncertain.
Nevertheless, it is plausible that surgery to correct spinal
scoliosis is not indicated in all DMD patients (level 2)
[3,10]. The criteria suggested by Yamashita et al. predict-
ing the progression of scoliosis may still be relevant and
could be applied to patients with a diagnosis of DMD. The
decline in pulmonary function is presumably correlated
with the progression of scoliosis (level 2) [3,10]. The
decline in vital capacity is, however, expected to occur as
part of the natural history of the condition in patients
with DMD and/or SMA and this is not necessarily causally
related to the development of scoliosis. It is imperative
that the diagnosis of DMD is confirmed by DNA analysis.
This may help to uncover which proportion of established
DMD patients does not develop a progressive scoliosis.
Recommendation
▪ It is important to find out whether a child with DMD
belongs to the small minority that does not develop a
severe scoliosis. For this purpose, the respiratory function
should be monitored in children with DMD, since the
vital capacity is a possible indicator of the progression of
scoliosis.
Factors affecting the progression of scoliosis in SMA type 2
Evidence
Progressive spinal deformity occurs in all children with
SMA type 2 (workgroup opinion (WO)).
Discussion/conclusion
The incidence of scoliosis in SMA type 2 is 100%. Hence,
all children with SMA type 2 are at some time indicated
for surgical intervention (level 4).
Recommendation
▪ All children with SMA type 2 should be operated to cor-
rect the spinal deformity at some time point.
Conservative treatment of scoliosis in DMD
Evidence
Brace treatment and sitting orthoses cannot prevent the
development or progression of scoliosis in DMD patients
[11,12]. Some findings suggest that prolongation of walk-
ing by the use of orthoses can prevent a rapid progression
of scoliosis in DMD patients between 13 and 15 years of
age [11,13]. However, Bakker et al. [14] concluded in a
review of 35 studies that it is uncertain whether knee-
ankle-foot orthoses can prolong functional walking,
although it seems that the use of knee-ankle foot orthoses
can prolong assisted walking and standing.
There is no evidence that physical training can influence
the evolution of muscular dystrophies in the long term. If
the patient rejects surgical intervention, orthotic treat-
ment or seating adaptations build on the patients' wheel-
chair can be beneficial to improve the sitting comfort and
to prevent decubitus.
Discussion/conclusion
Findings in literature and experience from experts indicate
that orthoses do not prevent the development or progres-
sion of scoliosis in DMD (level 3) [11,12]. Therefore,
orthoses should not be recommended for this purpose.
Rodillo et al. [13] presented evidence that prolongation of
the walking ability by the use of long leg braces may pre-
vent the rapid progression of scoliosis in DMD patients
between 13 and 15 years of age (level 3). However, these
findings have not been corroborated since. In addition, it
is uncertain if patients who maintained their walking abil-
ity until the age of 13 did not have a milder form of DMD.
In addition, Bakker et al. [13] concluded that it is uncer-
tain if knee-ankle-foot orthoses can prolong functional
walking. It is concluded that the evidence is not sufficient
to recommend the use of long leg braces to prevent scol-
iosis in DMD patients.
Recommendation
▪ Orthoses are not recommended to prevent the develop-
ment or progression of scoliosis in DMD patients.
▪ For patients who reject surgery sitting-orthoses can be
considered for improvement of sitting comfort.
Conservative treatment of scoliosis in SMA type 2
Evidence
Development of scoliosis in patients with SMA type 2 is
inevitable. Orthopedic treatment with a spinal brace or
long leg braces does not affect the course of scoliosis
development [15,16]. There are no data suggesting that
orthoses in general influence scoliosis progression in SMA
type 2 patients.
It is experienced in practice, however, that spinal braces to
improve comfort and sitting balance are appreciated by
patients with SMA type 2 in the preoperative phase. On
the other hand, rigid spinal braces were shown to have a
negative influence on the respiratory function [17].
Discussion/conclusion
Spinal braces and sitting orthoses do not prevent the
development or progression of scoliosis in SMA type 2
(level 3) [15]. Walking with long leg braces cannot prevent
the development or progression of scoliosis in SMA type
2 (level 3) [16]. A rigid spinal brace has a negative effect on
respiratory function (level 3) [17].Scoliosis 2008, 3:14 http://www.scoliosisjournal.com/content/3/1/14
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Recommendation
▪ Orthoses are not recommended to prevent the develop-
ment or progression of scoliosis in SMA type 2 patients.
▪ In the preoperative phase a non rigid spinal brace or sit-
ting orthosis can be considered for the improvement of
comfort and sitting balance.
Steroid treatment of scoliosis in DMD
Evidence
A few studies indicate that corticosteroids may delay the
development and progression of scoliosis in DMD
patients [6,18,19]. In a non-randomized comparative
study, it was found that a smaller percentage of DMD
patients treated with Deflazacort (a prednisolon deriva-
tive) developed scoliosis and that progression of scoliosis
was less severe compared to patients that did not receive
corticosteroids [6].
Discussion/conclusion
A significant effect of long term treatment with corticoster-
oids on the prevalence and progression of scoliosis was
found (level 2) [6,18,19]. Hence, treatment with corticos-
treroids may be considered for this purpose. A Dutch
guideline is already available for the use of corticosteroids
in DMD patients [20]. This guideline recommends the use
of prednisone in relative low doses, which reduces the
chance of side-effects, including osteopenia or osteoporo-
sis.
Recommendation
▪ Treatment with corticosteroids to prevent the develop-
ment or progression of scoliosis in DMD patients may be
considered, even if the patient is wheelchair-bound.
▪ It is recommended to follow the Dutch guidelines [20]
for the usage of corticosteroids in DMD patients.
Contractures in DMD
Evidence
In a retrospective study of 45 DMD patients, Furderer et al.
[21] describe a positive correlation between spinal con-
vexity and hip contracture. However, causal relationships
were not established. In a retrospective study of 54
patients Chan et al. [22] found that there was a correlation
between migration percentage of the femoral head and
scoliosis. They suggested that scoliosis potentiated the
development of hip subluxation and dislocation in DMD.
Discussion/conclusion
Although a correlation has been established between spi-
nal convexity and hip contracture [21,22], no indications
can be found in literature that contractures in the lower
extremities contribute to the development or progression
of scoliosis (level 3). Based on retrospective data, Chan
[22] even suggests a reverse causality, i.e. scoliosis poten-
tiates the development of hip subluxation. However, no
studies are available using X-rays of pelvis and spine to
follow the development of scoliosis and contractures in
young DMD patients.
Recommendation
▪ Corrective surgery of lower extremities in order to pre-
vent the development or progression of scoliosis is not
recommended in DMD patients.
Contractures in SMA type 2
Evidence
Granata [23] studied 49 SMA patients, of which 35 were
type 2. He described a linear correlation between migra-
tion percentage of the hip and scoliosis. However, no
causal relationship between contractures in the lower
extremities and scoliosis was established.
Discussion/conclusion
Based on a linear correlation between age and migration
percentage, and between migration percentage and degree
of scoliosis, Granata et al. suggested that hip subluxation
and scoliosis develop simultaneously due to muscle weak-
ness around the hip [23]. In their study, they also show
that the pattern of scoliosis does not match the type of pel-
vic obliquity in a consistent way. This indicates that con-
tractures in the lower extremities do not govern the
development of scoliosis and supports their suggestion
that muscle weakness is the common cause of both hip
subluxation and scoliosis (level 3).
Recommendation
▪ No evidence exists for a causal relationship between con-
tractures in the lower extremities and scoliosis. Hence,
corrective surgery of lower extremities in order to prevent
the development or progression of scoliosis is not recom-
mended in SMA type 2.
2. Preoperative phase
General
In the preoperative phase the respiratory and cardiac func-
tions should be assessed according to an explicit protocol
in relation to both the timing of surgery and possible post-
operative complications. Unfortunately, available evi-
dence about these factors in DMD and SMA type 2
patients is limited. All studies concerning the course of
spinal surgery in DMD and SMA type 2 patients are non-
comparative retrospective studies. Some studies suggest
guidelines for preoperative protocols.
Preoperative protocol respiratory function
Evidence
The relationship between deterioration of pulmonary
function and the occurrence of postoperative complica-Scoliosis 2008, 3:14 http://www.scoliosisjournal.com/content/3/1/14
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tions is uncertain. Some indications are given that preop-
erative pulmonary function is an important factor based
on experience and small cohort studies [24,25]. However,
few studies were found in which the relationship between
pulmonary function and postoperative complications was
quantified [26-28]. Jenkins et al. [27] correlated preoper-
ative respiratory function tests with postoperative respira-
tory complications in 48 DMD patients. They found that
the percentage of predicted vital capacity provided the
best indicator of outcome, and values of less than 30%
were associated with major respiratory complications. Yet,
in another study no different complication rates were
found comparing DMD patients with a preoperative
forced vital capacity (FVC) of more than 30% and patients
with a vital capacity of less than 30% after spinal surgery
[26,28]. They concluded that spinal fusion surgery can be
offered to patients with DMD even in the presence of a
low vital capacity [26,28]. Gill at al. [29] studied a small
group of patients with progressive scoliosis and rare forms
of muscular dystrophy/myopathy with respiratory failure.
They concluded that patients with preexisting respiratory
failure on nocturnal noninvasive ventilation can be safely
operated for deformity correction [29].
Several studies have evaluated the effect of spinal stabili-
zation in DMD patients on the rate of decline in respira-
tory function [9,27,30-33], but the results are at variance.
Some studies comparing operated with non-operated
patients found no difference in rate of decline [9,30,33].
Yet others found that spinal fusion reduced the rate of res-
piratory decline [27,31,32].
No literature is available about the benefit of preoperative
practice with non-invasive ventilation in patients with
neuromuscular scoliosis. However, it is the opinion of the
workgroup that it may be beneficial to practice with non-
invasive ventilation in patients with FVC ≤ 40% of the pre-
dicted value and/or indicated by arterial blood gas
analysis.
Discussion/conclusion
The relationship between preoperative pulmonary func-
tion and postoperative complications is indistinct (level 3)
[9,26,26-28,28-30,33]. The traditionally accepted lower
limit of vital capacity to allow spinal surgery in DMD
patients is not validated by evidence (level 3) [27,31,32].
Spinal fusion may reduce the rate of decline in respiratory
function.
Recommendation
▪ Respiratory function should be tested in all patients with
neuromuscular scoliosis.
▪ In case of seriously impaired pulmonary function (FVC
≤ 40% of predicted value) it is advised to practice preop-
eratively with noninvasive ventilation.
▪ In case of seriously impaired pulmonary function (FVC
≤ 40% of predicted value) it is advised to teach patients
techniques, such as air stacking, which can assist patients
with their sputum evacuation.
Preoperative protocol cardiac function
Evidence
Literature about cardiac dysfunction with regard to spine
surgery in neuromuscular diseases is scarce. Cardiac dys-
function, as a result of cardiomyopathy, typically occurs
in patients with DMD and seldom in patients with SMA
type 2. The risk of surgery is greatly increased by cardiac
dysfunction or rhythm abnormalities [34]. Therefore pre-
operative medical therapy for cardiac dysfunction in
patients with muscular dystrophy is required. The cardio-
myopathy of DMD is characterized by fibrosis of the pos-
terobasal and contiguous lateral wall of the left ventricle,
and is associated with arrhythmia, ventricular dilatation
and cardiac insufficiency.
Discussion/conclusion
Neuromuscular disorders, especially DMD, often involve
cardiac problems in the course of the disease, such as a
reduced contractility and arrhytmia. Therefore a preoper-
ative consultation at the pediatric cardiologist (with
echocardiography (ECG) and, in case of arrhythmia, a 24
hour holter ECG) is required for DMD patients (ACC/
AHA guidline 2002) [35]. It is the opinion of the work-
group that severe cardiac dysfunction in DMD may be an
indication for early spinal surgery or a contraindication
for surgery (level 4).
Recommendation
▪ The pediatric cardiologist should be consulted during
the preoperative planning of surgery in DMD patients.
Preoperative protocol other considerations
Evidence
The usefulness of multidisciplinary preoperative proto-
cols has never been studied. However, it is generally
agreed that the preoperative planning of spinal surgery in
neuromuscular scoliosis requires a multidisciplinary
approach.
Discussion/conclusion
Based on expert opinions it is recommended that atten-
tion is given to nutrition, bowel and bladder function,
contractures, blood coagulation, medication, and postop-
erative care, besides pulmonary and cardiac function (level
4) [36]. Furthermore, several issues should be discussed
preoperatively with the parents. These include the possi-Scoliosis 2008, 3:14 http://www.scoliosisjournal.com/content/3/1/14
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bility of postoperative ventilation (with tracheostomy in
particular) and resuscitation decision making. The sever-
ity of cardiac and pulmonary problems can be a reason to
discard surgery.
Recommendation
▪ Attention should be given to nutrition, bowel and blad-
der function, contractures, blood coagulation, medica-
tion, and postoperative care during the preoperative
phase.
▪ Preoperatively, resuscitation decision making should be
discussed with the parents.
▪ Preoperatively, the possible requirement of postopera-
tive ventilation (tracheostomy) should be discussed with
the parents.
Anesthetic considerations
Evidence
No studies were found specifically addressing anesthesia
in SMA type 2 or DMD patients, but useful information
can be obtained from several mixed series of patients with
neuromuscular disorders treated according to explicit
guidelines [24,25,37-39]. Best practice for perioperative
blood management and spinal cord monitoring can be
obtained from general literature about spine surgery.
Hence, all recommendations are based on expert opin-
ions only. Recommended procedures are hypotensive
anaesthesia, the use of cell salvage and Tranexamic acid,
hemodilution, hemodynamic monitoring, and careful
positioning of a nasogastric tube and (Foley catheter or)
indwelling urinary tract catheter. In addition, it is impor-
tant to maintain normothermia in order to prevent hem-
orrhagic complications and clotting problems. The use of
anticholinergica should be avoided.
Discussion/conclusion
Invasive hemodynamic monitoring, normvolemic
hemodilution to reduce exposure to homologous blood-
products, insertion of a nasogastric tube and (Foley cath-
eter or) indwelling urinary tract catheter, careful
maintenance of normothermia are described as expert
opinions in literature (level 4) [25,37-39].
Recommendation
Peri-operative monitoring of patients with neuromuscular
disorders should comply with the standard guidelines for
major spine surgery.
3. Operative treatment
Spinal fixation and fusion
Evidence
Posterior segmental fixation (in particular pedicle screw
fixation or sublaminar wires) was found to be superior to
distraction spondylodesis with Harrington rod instru-
mentation, since it gives better preservation of correction,
less rod failure, and does not require postoperative brac-
ing [40-42]. Anterior release and/or instrumentation and
fusion in DMD and SMA is not advised [43]. With respect
to the fusion length, spondylodesis up to Th4 or Th5
resulted in a higher rate of late deformity compared to
instrumentation to Th3 or higher [42]. Pelvic fixation did
not prove to be superior to instrumenting to L5 in DMD
patients [44]: fixation to S1 improves the possibilities for
correction of severe curves, but it is associated with loss of
function, increases the duration of surgery and blood loss,
and increases the complication rate. Fusion to L5 in neu-
romuscular scoliosis proved to be equivalent to fusion to
the pelvis and the presence of a mobile lumbosacral joint
may assist in seating and transfer activities [45].
The use of allograft bone for posterior fusion reduces
operation time and blood loss compared to the use of
autologous bone graft with similar clinical outcomes [46].
No studies are available on bone substitutes.
Early surgery is favored in DMD patients based on the pro-
gression of the curve (at 12 years the Cobb's angle was 20°
versus a Cobb's angle of 50° at 14 years) [40,47]. No lit-
erature is available about SMA patients under the age of
ten. If fusion is performed on these young children, the
growth of the trunk should be taken into account to pre-
vent torsion of the spine (crankshaft). The use of growth-
sparing instrumentation can be considered in patients
who have progressive spinal deformity and significant spi-
nal growth remaining. Luque 'trolleys' have been used to
control progressive curves using segmental instrumenta-
tion. The use of dual growing-rod technique in DMD and
SMA type 2 has not been reported up to now.
Discussion/conclusion
Several aspects of spinal fixation in neuromuscular scolio-
sis have been evaluated. In DMD patients early surgery is
favored (level 3) [40,47]. Posterior segmental instrumen-
tation and fusion with the use of allograft bone combined
with locally harvested bone is advocated in neuromuscu-
lar scoliosis (level 3) [40-43,46]. Correction of scoliosis
and instrumentation should be at least from Th2 or Th3
(level 3) [42]. The use of dual growing-rod technique has
not been reported up to now, however, repeated lengthen-
ing every 6 months may induce significant risks (serial
anaesthetics, instrumentation problems, wound infec-
tions) (level 4). Pelvic fixation gives better possibilities to
correct severe curves, but increases time of surgery and
blood loss (level 3) [44,47-49]. All studies are retrospec-
tive cohort studies (level C, D) and hampered by selection
bias, however, the findings are consistent with the experi-
ence of the work group members. The SMA patients tend
to fall into 2 groups surgically: (1) those who develop aScoliosis 2008, 3:14 http://www.scoliosisjournal.com/content/3/1/14
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significant scoliosis aged 1–3 years, and (2) those who
develop a curve at the age of 4–7 years. The first group can
be well managed with lengthening systems. In the second
group, the curve usually remains flexible enough to delay
surgery until the age of 7–9. At this age, although a spinal
fusion will result in some loss of final sitting height and
probably chest volume, the benefits of a single surgical
procedure outweigh the risks of multiple lengthening pro-
cedures. The use of multiple pedicle screws around the
curve apex may reduce the risk of crank-shafting (level 4).
Recommendation
▪ The indication for surgical correction of scoliosis should
be made early in DMD en SMA type 2 patients (Cobbs
angle 20°), such that surgery is less complicated, shorter,
and safer and it is more likely that the pelvis can be left out
of the fusion trajectory.
▪ In DMD, posterior spinal fusion should be performed
from high thoracic (Th2-3) at least to L4 or L5. Pelvic fix-
ation gives better possibilities to correct severe curves, but
increases time of surgery and blood loss.
▪ In SMA type 2 posterior spinal fusion should be per-
formed. The technique varies with age and should con-
sider possible remaining growth.
▪ Instrumentation should be segmental.
▪ Allograft bone can be used supplemented with locally
harvested autologous bone or bone substitutes.
Spinal cord monitoring
Evidence
The value of spinal cord monitoring for prevention of
neurologic deficits during scoliosis surgery has generally
been acknowledged [50]. In nine studies spinal cord mon-
itoring in neuromuscular scoliosis has been described: the
use of somatosensory evoked potential (SSEP) as a
method for monitoring was assessed in seven [51-57],
intraoperative transcranial electrical motor evoked poten-
tial (TCE-MEP) monitoring was evaluated in two studies
[58,59]. The SSEP technique showed impermissible high
variance if only one recording site was used [52], however,
if the SSEPs were recorded from multiple sites located cor-
tically, subcortically, and peripherally reliable values are
obtained in 95–100% of the patients [51,53-57]. The
more recent TCE-MEP method was described in a pilot
study with 9 patients [59] and compared to SSEP in a pro-
spective descriptive study including a group of 29 neu-
romuscular scoliosis patients and a group of 39 patients
with cerebral palsy scoliosis [58]. It was concluded that
both transcranial electric motor and posterior tibial nerve
somatosensory-evoked potentials can be monitored relia-
bly in most patients with neuromuscular scoliosis. Advan-
tages of TCE-MEP relative to SSEP are the ability to test
motor function during surgery and the possibility to easily
adapt the recording sites to the remaining motor function.
Discussion/conclusion
Pre-operative neurological function varies considerably
between patients with neuromuscular scoliosis and differs
from healthy subjects. However, also for these patients it
is important to prevent any clinical damage to the spinal
cord to assure preservation of the remaining neurological
functions. Spinal cord monitoring has shown to be appli-
cable also in neuromuscular scoliosis (level 3) [51,53-59].
The methods of SSEP monitoring have been improved by
the use of multiple recording sites, TCE-MEP allows for
direct testing of important motoric functions.
Recommendation
▪ Spinal cord monitoring is recommended for neuromus-
cular scoliosis surgery. Both SSEP and TCE-MEP can be
monitored reliably.
Post-operative care
Evidence
Patients with DMD and SMA type 2 have a high risk of
postoperative complications. The most frequent postoper-
ative problems are related to the limited respiratory capac-
ity of the patients. Cardiac dysfunction is rarely a cause for
postoperative ventilation. No literature could be found
about the postoperative treatment of DMD or SMA type 2
patients. The duration of postoperative ventilation is
determined individually and is less than 36 hours in most
cases [26,27]. The guidelines for placement in the pediat-
ric intensive care unit (PICU) of the Dutch Pediatric Soci-
ety are: ventilation >24 hours (children > 1 year) or failure
of more than one organ system.
Discussion/conclusion
All statements are based on expert opinions (level 4). Fre-
quent use of non-invasive ventilation following extuba-
tion and cough assist machines in patients with an
ineffective cough, intensive respiratory physical therapy,
as well as early mobilisation of the patients on a reclining
wheelchair may reduce the risk of postoperative pulmo-
nary infection. The workgroup follows the guidelines of
the Dutch Pediatric Society with respect to pediatric inten-
sive care. Hence, only children without expected cardiac
or pulmonary problems can be operated in a center with-
out a pediatric intensive care unit.
Recommendation
▪ Only neuromuscular scoliosis patients older than 1 year,
without respiratory complaints, without nightly hypoven-
tilation, without cardiomyopathy requiring medication,
with adequate pulmonary function, and where no adverse
events are expected during surgery may be operated in aScoliosis 2008, 3:14 http://www.scoliosisjournal.com/content/3/1/14
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center without a pediatric intensive care unit. This is in
accordance with the guidelines of the Dutch Pediatric
Society.
Therapeutic effect of scoliosis surgery on cardiac and 
pulmonary function in DMD
Evidence
All evidence is based on retrospective cohort studies (level
3). The effect of scoliosis surgery on cardiac function has
not been studied. Comparison between pre- and post
operative pulmonary function reveals no improvement
due to correction of scoliosis. Long term studies show that
decline of pulmonary function in DMD patients is
unchanged in operated patients relative to patients who
had no surgery [9,30,60]. Galasko et al. [32] reported a
temporary halt in the decline of pulmonary function after
scoliosis surgery, however after 2 years follow-up, the
results were comparable to those reported by the other
authors. Eagle et al. [61] found in a retrospective cohort
study of 100 DMD patients that survival was improved in
patients who received nocturnal ventilation and further
improved in patients who received spinal surgery, how-
ever, due to the study setup no strong conclusions can be
drawn.
Discussion/conclusion
Decline in pulmonary function in DMD patients is not
influenced by scoliosis surgery (level 3) [9,30,32,60].
Recommendation
▪ When considering spinal surgery for DMD patients, the
effects of surgery on heart and lungs do not play a role in
the decision making.
Therapeutic effects of scoliosis surgery in SMA type 2
Evidence
A few retrospective cohort studies reported the effects of
spinal surgery on cardiac and pulmonary function in SMA
type 2 patients. Most studies evaluate a mixed group of
SMA patients. In a few cases improvement of the FVC after
spinal surgery was reported [41,43].
Discussion/conclusion
In theory, spinal surgery could lead to improvement of
pulmonary function, since stabilization of the spine stabi-
lizes the chest cavity resulting in a reduction of the intra-
abdominal pressure. Early intervention could thereby
enable a better development of pulmonary function.
However, presently not enough evidence exists to support
this hypothesis (level 3).
Recommendation
▪ Early scoliosis surgery may be considered although there
is no evidence that spinal surgery decelerates the deterio-
ration of cardiac and/or pulmonary function.
Therapeutic effects of scoliosis surgery on activities of 
daily living (ADL)
Evidence
All studies are retrospective cohort studies and no com-
parison is made between treatment and natural course.
Studies with long term follow-up all mention an
improved sitting balance and subjective quality of live
[41,43,62-64]. Brown [41] and Furumasu [64] reported
improvement of several functions, however, other func-
tions such as eating and personal care worsened.
Discussion/conclusion
Sitting balance is an important function for patients with
neuromuscular scoliosis. Scoliosis surgery can improve
sitting balance (level 4) [41,43,62-64]. The results are
dependent on the surgical technique and the time of sur-
gery. However it has adverse effects on some arm func-
tions (eating, personal care). The decline of arm function
is specifically seen after scoliosis surgery with trunk
lengthening.
Recommendation
▪ Early scoliosis surgery is recommended in order to
obtain a good and lasting improvement of the sitting bal-
ance. Education about the alteration of the trunk position
and associated changes in arm function is necessary.
4. Precare and aftercare
Information
Evidence
No scientific research is available about informing
patients and parents about spine surgery in neuromuscu-
lar scoliosis. However, the importance of adequate infor-
mation has been emphasized [65,66] and is endorsed by
the work group.
Discussion/conclusion
The surgical techniques in neuromuscular scoliosis are
similar to those in scoliosis surgery in patients without
neuromuscular disease. However, the complexity of mul-
tiple physical handicaps demands specific pre-operative
and peri-operative care. In two Dutch hospitals informa-
tion brochures were available. Parents and patients
should be adequately informed about the pre-operative
examinations, surgery, post-operative care, risks, and con-
sequences of the surgery (level 4). Both rehabilitation spe-
cialist and orthopedic surgeon should inform the parents
and the patient about these issues, possibly in a joint con-
sult.
Recommendation
▪ Pre-operative preparation, surgery and after-care should
be given by an experienced multidisciplinary team of spe-
cialists.Scoliosis 2008, 3:14 http://www.scoliosisjournal.com/content/3/1/14
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▪ Patients and parents should be well informed about all
aspects of the treatment and the possible adverse events,
including the aims of the surgery and the consequences
for daily functioning (such as reduced arm function).
Patients with physical and mental disability
Evidence
No evidence is available.
Discussion/conclusion
The prevalence of mental retardation in DMD is approxi-
mately 40%. SMA type 2 and mental retardation are not
related. Pre- and postoperative care and information
should be adjusted to the mental capacity of the patient
(level 4).
Recommendation
▪ In patients with a mental handicap information should
be attuned.
Postoperative care and aftercare
Evidence
An average hospital stay of 14 days was reported by Ben-
son et al. [37]. Patients were mobilize in a wheel chair
from day 5. Cotton [67] states that special care should be
taken to prevent infection of the airways. He reports that
mobilization in a wheelchair takes place from day 2. This
is in agreement with other literature. No evidence was
found about aftercare.
Discussion/conclusion
Patients are usually mobilized in a wheelchair from day
2–5. Nursing care comprises prevention of airway infec-
tions and decubitus, wound care, nutrition, and pain
management (level 3) [37,67].
In the absence of evidence the work group has formulated
their expert opinions on this subject (level 4):
￿ Care is more intensive and complex during the first
period after discharge from the hospital because children
are weakened temporarily by the surgery and the healing
process of the bony fusion takes 3–9 months. Rotation in
the spine and hip flexion exceeding 90° are not allowed
in this period. This has consequences for turning and lift-
ing of the patients. A mobile hoist for the task of transfer-
ring a patient should be used. Before discharge the
physical therapist should give instructions about lifting
and sitting upright.
￿ In consultation with the general practitioner temporary
homecare may be arranged.
￿ Measures should be taken to take care of changes in arm
function due to the lengthening of the spine.
￿ For the recovery period at home, homework assign-
ments can be provided.
￿ Because of the altered sitting position, the wheelchair
needs to be adapted. Care should be taken that the proce-
dures to realize these changes are started timely. The ergot-
herapist supervises this.
￿ The wheelchair should be adapted to optimize sitting
comfort.
Recommendation
▪ After deciding on scoliosis surgery, the orthopedic sur-
geon and rehabilitation specialist should anticipate possi-
ble post-operative (temporary) problems and alterations
in required care.
▪ The (electric) wheelchair should be adapted in order to
support a position in which sitting balance and head bal-
ance can be maintained with the least effort for the child.
Postoperative bracing
Evidence
No comparative studies are available about post-operative
bracing. Large variation exists in policies regarding the use
of post-operative braces. Braces are often not prescribed,
but if prescribed most often synthetic braces are used for
a post-operative period of 3 months [63,68-72].
Discussion/conclusion
Policies regarding post-operative bracing vary considera-
bly (level 3). The workgroup comments that with the cur-
rent instrumentation techniques braces are redundant
and can be unfavorable for respiratory recovery, especially
at the early stage following surgery when pulmonary func-
tion is significantly reduced.
Recommendation
▪ Post-operative spinal braces are not recommended with
the modern instrumentation techniques.
Head and Neck
Evidence
No literature could be found about the effectiveness of
rehabilitation treatment after scoliosis surgery to prevent
obliqueness of the head/neck.
Discussion/conclusion
No evidence is available concerning the post-operative
treatment of head and neck posture. It is observed that
sometimes a scoliotic deformation remains above the
fusion trajectory. This should be taken into account when
adaptations are made to the wheelchair. Possibly a head
support is needed.Scoliosis 2008, 3:14 http://www.scoliosisjournal.com/content/3/1/14
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Recommendation
▪ Attention should be given to any changes in head and
neck balance after scoliosis surgery. Possibly extra provi-
sions or adaptations of the wheelchair may be needed.
Management
Evidence
No studies have been conducted about the management
of neuromuscular scoliosis.
Discussion/conclusion
Recommendations are all based on experience and opin-
ions of experts within the workgroup (level 4).
In the pre-operative phase, orthopedic surgeon and reha-
bilitation specialist preferably inform the parents and
patients about the surgery, care, and consequences. The
pediatrician, center for ventilation at home, and/or pul-
monary specialist have to be consulted for screening of the
pulmonary function. In DMD patients, the cardiologist
has to be consulted for possible cardiomyopathy. Pre-
operative screening must be performed as described
above.
During surgery the anaesthesiologist considers all specific
aspects of the neuromuscular disease (as described
above). After surgery the patient is admitted at the inten-
sive care unit. A threatening cardiomyopathy or respitory
insufficiency requires monitoring at the pediatric inten-
sive care. A physiotherapist coaches the child with respira-
tory techniques and coughing.
After surgery, the orthopedic surgeon has regular follow-
ups and checks the sitting position in the wheelchair. The
rehabilitation specialist verifies if adequate care is pro-
vided at home and coordinates adaptation of facilities.
Recommendation
▪ Spine surgery in neuromuscular scoliosis requires a
multidisciplinary team of specialist experienced with
treatment of these patients. Close cooperation is needed
all specialists involved, including physiotherapist and
nursing staff.
▪ The use of a checklist for treatment and post-operative
care of spine surgery in neuromuscular scoliosis is
advised.
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